Tirzepatide-Specific Safety Considerations GI symptoms are generally mild to moderate Risk of hypoglycemia when used with insulin or sulfonylureas Rare risk of pancreatitis (class effect) Possible thyroid C-cell effects (class warning) Heart rate increases have been documented, but are generally modest Retatrutide-Specific Safety Considerations Higher overall rate of side effects compared to tirzepatide in Phase 2 data More pronounced heart rate increase this is a dose-dependent effect directly related to glucagon receptor activation (glucagon is known to increase heart rate in pharmacological doses) At 12 mg doses, some participants experienced increases in heart rate of 46 bpm above baseline
Most patients experience no adverse reactions, but in rare cases, individuals may report symptoms such as mild bloating, cramping, allergic reactions (rash or itching), or a metallic taste in the mouth
Some MyLupusTeam members find that walking, gentle stretching, and yoga help their lupus symptoms
Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes
Enhance the expression of osteogenic markers Osteocalcin (OC): Upregulates OC mRNA and protein expression by 20% -30%
guidesApril 25, 20266 min read 4 peptides in one vial but the math changes everything